News Feed
Clear Blue Technologies Launches Smart Pico-Grid Product, Entering New Satellite Wi-Fi and IoT Markets
New product unlocks two significant new markets for Clear Blue to drive growth in 2022 […]
Popular
News Feed
FCK Foundation licenses StrikeForce’s Mobile & Authentication Technologies to Protect Wallet Transactions
StrikeForce to Receive 50% of Net Proceeds on All Transaction Fees EDISON, N.J., March 08, 2022 (GLOBE NEWSWIRE) — StrikeForce Technologies, Inc. (OTCQB: SFOR), a cyber security company that provides next-gen cyber, privacy & data protection solutions […]
News Feed
GOLDEN INDEPENDENCE FORMS JOINT VENTURE WITH AMERICAS GOLD EXPLORATION INC.
Vancouver, British Columbia – December 13, 2021 – Golden Independence Mining Corp. (CSE: IGLD, OTCQB:GIDMF, FRA:6NN) (the “Company”) is pleased to announce it has formed the Joint Venture with Americas Gold Exploration Inc. (“AGEI”) to advance […]
News Feed
Citius Pharmaceuticals Completes Enrollment in the Pivotal Phase 3 Study of its Cancer Immunotherapy I/ONTAK for the Treatment of Cutaneous T-Cell Lymphoma
Topline study results expected in the first half of 2022; Biologics License Application (BLA) filing anticipated in the second half of 2022 […]
News Feed
BluMetric Announces Strong Financial Results for Q3 2021
“Our team at BluMetric continues to deliver excellent results, putting the Company in a solid position to focus on future growth as economic activity continues to ramp up,“ says Scott MacFabe, CEO of BluMetric. […]
News Feed
Pennexx’s CEO Vincent Risalvato Interviewed with The Wall Street Analyzer
PHILADELPHIA, PA / ACCESSWIRE / July 29, 2021 / Pennexx Foods (OTC PINK:PNNX) Vincent Risalvato, CEO of Pennexx, conducted an interview where he talks about the updated launch of https://YourSocialOffers.com, its second quarter of profitability, its goals […]
CEO Interviews
808 Renewable Energy Corporation (OTC Pink: RNWR)
Interview Update with David Chen, President and CEO […]
News Feed
Ocuphire Announces Addition to the Russell Microcap® Index
FARMINGTON HILLS, Mich., June 11, 2021 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on development and commercialization of therapies for the treatment of several eye disorders, today announced […]
Popular
News Feed
Ocuphire Granted Two New U.S. Patents Covering Late-Stage Drug Candidate Nyxol®, Including for the Treatment of Presbyopia
Newly Issued Claims Extend Patent Protection to Year 2039 for Nyxol®Combination Therapy for Presbyopia […]